Recently, the locally aggressive LFLNT has been described, a tumor entity habouring NTRK-fusions, with similar morphology as dermatofibrosarcoma protuberans and co-expression of CD34, S100 and pan-TRK [8, 20, 39]. The gene discussed is TPM3; the disease is neoplasm.